chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; some mild jaw pain, like a dull tooth ache/jaw/tooth pain; some mild jaw pain, like a dull tooth ache/jaw/tooth pain; This is a spontaneous report from a contactable consumer reporting for himself. A 66-year-old male patient started to receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: unknown) via an unspecified route of administration (left arm) on 07Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient wanted to know if there was a known jaw or tooth pain side effects after receiving the COVID vaccine. 15 minutes after injection, he started having mild jaw pain, described as a dull tooth ache, that has not subsided yet (24 hours later). Patient reported that the jaw/tooth pain is making him eat on the other side this morning. Patient stated he was seeking some reassurance. He mentioned he thought he was a tough guy and would not have side effects but within 2 minutes (also reported within 60 seconds or less than 5 minutes of receiving the vaccine) he had a headache. When he developed the headache, he did pull over and waited it out, but he stated that before he left the clinic after getting his vaccine, he did have some mild jaw pain, like a dull tooth ache, and he still feels it. He stated that he does not believe it could be a tooth problem, and that it had to have been triggered by the vaccine because it occurred 15 minutes after he got the vaccine. Patient was wondering if there are any know jaw problem side effects with the vaccine. He stated that it feels like a dull pain on just one side. Outcome of the event some mild jaw pain, like a dull tooth ache/jaw/tooth pain was not recovered while unknown for headache.  Information about Batch/Lot number has been requested.
About 4 weeks after the f/u shot, I experienced joint pain, in the foot, ankles, knees, neck, arm, elbow and hand. 2/10/09 Received PCP medical records of 12/16-12/18/2008. FINAL DX: joint pain Records reveal patient experienced joint pain x approx 2 weeks.  Seen by accupuncturist 12/15.  Exam was WNL.  Tx w/meds & labs done.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX23 (lot #, dose and route not reported). On an unknown date, a second dose of PNEUMOVAX23 was inadvertently administered to the patient who also received PNEUMOVAX23 one month prior to the second dose. The dose was outside of recommended guidelines. No adverse effect was reported. Additional information has been requested.
low grade fever; chills; significant GI upset including diarrhea; significant GI upset including diarrhea; throbbing, heavy and fuzzy head; fatigue; sore arm; throbbing, heavy and fuzzy head; This is a spontaneous report from a contactable consumer. A 29-year-old female patient received second dose of BNT162B2 (PFIZER COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 13Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Apr 2021, the patient experienced low grade fever, chills, significant gastrointestinal upset including diarrhea, throbbing, heavy and fuzzy head, fatigue and sore arm. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
had received both doses of the Pfizer Covid vaccine as well as a booster dose and had recently been diagnosed with a Covid infection; had received both doses of the Pfizer Covid vaccine as well as a booster dose and had recently been diagnosed with a Covid infection; booster dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group. The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Oct2021 (Lot number: FF2590, Expiration Date: 30Dec2021) at the age of 51 years as dose 3 (booster), single, administered in arm left, administration date 07Feb2021 (Lot number: EL9269) as dose 2, single and administered in arm left, administration date 16Jan2021 (Lot number: EZ3249) as dose 1, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: Patient history : No, Patient's medical history:None. There were no concomitant medications. The following information was reported: IMMUNISATION (medically significant) with onset 09Oct2021, outcome "unknown", described as "booster dose"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 04Jan2022, outcome "unknown" and all described as "had received both doses of the Pfizer Covid vaccine as well as a booster dose and had recently been diagnosed with a Covid infection". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Jan2022) positive. No follow-up attempts are possible. No further information is expected.  Additional Information: On 04Jan2022, the patient was diagnosed with covid. The patient was not sure which test he had that came up positive for covid.  No follow-up attempts are possible. No further information is expected.
Red blotch developed on side of face 8 hrs after receiving vaccine. Also red blotch on left side of chest just below arm pit. Rash was some what itchy. Seen in student health and told if it continued next day - would give BENADRYL. No wheezing or other symptoms.
No adverse event. Patient is 12 but received 10mcg dose meant for 5--11 year olds.
pt recv vax & dx GBS; weakness x 2mo;c/o numbness inner thighs using walker at home;c/o fear of falling, fatigue;muscle strength & reflexes improved over last wk of hosp;pt exp diff getting up from low chairs w/o arm rests;lost of DTR's;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Feb2022 as dose 3 (booster), single (Lot number: 32030BD) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Recent weight loss revision surgery" (unspecified if ongoing). Patient had no known allergies. There were no concomitant medications, also reported as patient not received any other medication in 2weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid started from 06Sep2022 and stopped on 09Sep2022. Clinical course was reported as, on 08Sep2022 at 20:00, patient experienced symptoms of Throat had restriction or tightening. Patient not received any treatment for the symptoms and was recovering from symptoms.
not an adverse event. Pt given vaccine and is under 19 so i wanted to report the error.
First week: Chills & headaches. Second week: Heartburn & chest pain. Third week until now: Rashes (pimple-like) & reddish and itchy face and chest.
C/o lightheadedness and dizziness after vaccination. Didn't eat breakfast this morning, he only had water with lemon. Vital signs stable x 2; no preexisting health conditions; rested at vaccination station until discharge from clinic.
Initially, focal pain in left shoulder, subscapular. In susequent days more diffuse in location and more intense. Distribution shoulders and upper back, greater on left. Exacerbated by motion and pressure. Relieved by acetominophen.
Pt complain of dizziness p 10 mins of giving Anthrax Vaccine 0.5ml LD IM. Put pt in the room and lay in the bed propped both above chest. PT complain that tingling On left arm and pounding in both side of head. Called Dr and attended to pt immediately. VS BP 150 PP 76 RR 18 and Dr assist pt to observe for further adverse reactions. VS obtained again p 15 Mins BP 140/90 PP 60 RR 16 this time complain of itching on the back, neck and scalp with redness and puffiness on the face. Dr ordered BENADRYL 12.5 Mg/5ml 20 ml Given Stat. Orally then observe pt for further adverse reactions. VS obtained again p 10 mins BP 148/104 PP 60 RR 16. after 15 mins pt said that the puffiness and redness in the face is gone. No tingling sensation on arm and No more itching on neck back and scalp. 0945 Pt able to walk uses Bathroom for urination. Remind again of safety in case further adverse reaction.Team 1 reminded of pt condition and all orders carried out. Will notify code team for further of pt condition.
Sever muscle and joint pain from waist through hips and thighs to knees.; Sever muscle and joint pain from waist through hips and thighs to knees.; Numbness and tingling from knees to toes / Toes and tops of feet going completely numb; Tingling from knees to toes; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Sep2021 13:00 (Lot number: 301358A) at the age of 45 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Recent Cervical cancer", start date: Jul2021 (unspecified if ongoing), notes: Recent Cervical cancer, just completed treatments in July.; "known allergies: Most fresh fruits" (unspecified if ongoing); "known allergies: most fresh vegetables" (unspecified if ongoing); "known allergies: some nuts" (unspecified if ongoing), notes: known allergies: some nuts, NOT including peanuts; "if covid prior vaccination: Yes" (unspecified if ongoing). Concomitant medication(s) included: MONTELUKAST SODIUM; ADDERALL; TOPIRAMATE; LANSOPRAZOL. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FC3182, Vaccine Administration Time: 12:00 PM), administration date: 29Aug2021, when the patient was 45 years old, for COVID-19 Immunization. The following information was reported: MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 19Sep2021 17:00, outcome "not recovered" and all described as "Sever muscle and joint pain from waist through hips and thighs to knees."; HYPOAESTHESIA (non-serious) with onset 19Sep2021 17:00, outcome "not recovered", described as "Numbness and tingling from knees to toes / Toes and tops of feet going completely numb"; PARAESTHESIA (non-serious) with onset 19Sep2021 17:00, outcome "not recovered", described as "Tingling from knees to toes". Therapeutic measures were not taken as a result of myalgia, arthralgia, hypoaesthesia, paraesthesia.  Since the vaccination,  patient has not been tested for COVID.. case assessed as non serious and patient was not hospitalized.  Follow-Up (11Oct2021): Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a CMA (certified medical assistant) regards an unknown number of patients (no demographic details were provided). The medical history of the patients was unknown. The reporter stated that an unknown number of patients many have received VAQTA, RECOMBIVAX HB, (merck) VARIVAX, PEDVAXHIB and GARDASIL that was improperly stored. This report concerns RECOMBIVAX HB. No details were provided regarding the administration dates, dosing regimen or lot number. No adverse event was reported. This report is linked to the cases MARRS ID 1305USA003372, 1306USA007107, 1306USA007108 and 1306USA007109 which concern VAQTA, (merck) VARIVAX, PEDVAXHIB and GARDASIL respectively. Additional information has been requested.
Chills - minimal - 3-4 hours Headache - for 14-16 hours (was still lingering when I woke up after two days) I do get headaches during my menstrual cycle which happened to coincide with the first dose of the vaccine so it may have been exacerbated by that.
Information has been received from a consumer concerning her 16 month old daughter with mild diarrhea at the time of vaccination who on 2/25/2000, was vaccinated with the 1st dose of MMR. On 3/3/00, the pt experienced a febrile seizure characterized by movement of all four extremities. The pt was immediately taken to an ER where her temperature was recorded as 104.6F. The ER physician thought the pt had a right otitis media and prescribed a course of ampicillin therapy. The pt has no rash and no other symptoms. The following morning, the pt was seen by her own pediatrician who noted that she also had an otitis media in the left ear as well. The pt remained febrile for the next 5-6 days and was switched to bacitracin (Septra) when her temperature went away. The pt has not returned to daycare but is doing better. The pt's febrile seizure was considered an "other medical event." Additional information has been requested.
See attached sheet. Patient stated in pre-screening that after receiving the flu shot she vomits and gets a fever after each time but wanted the flu shot because, "its better to be sick for three days vs getting the flu." RN checked her screening form and administered the injection. Patient was instructed to stay in the monitoring area. After approximately 10 minutes, patient complained of feeling nauseous, before she could be moved to the cot she ran to the restroom. Writer followed and heard patient vomiting. Patient complained of vertigo, writer applied a cool rag and monitored her. After approximately 10 minutes patient stated she felt well enough to walk back to the room. Patient was instructed to stay on the cot. After another 10 minutes patient stood up and complained that her back felt like, "its on fire" and stated she didn't feel right. Writer offered to contact her superior, patient stated no. RN took vitals, BP 122/78, P 84, R 18. LHI nursing educator was contacted and talked with RN, patient was instructed to contact her own primary care physician and that this reaction has nothing to do with the flu vaccine but it still related to her kidney infection. Patient stayed in the monitoring area for approximately 15 minutes she stated she felt better and rejoined her office.
coughing , nausia  vomiting  hot flash, heat fluttering.,  treated with  EPi prednisone  and benadryl
Redness/swelling 3x4 cm of size (R) deltoid area painful and hot at palpation.
When giving patient the second dose of Moderna COVID vaccine the needle was not properly attached to the syringe.  Some of the vaccine was injected but most of it ran down his arm.  Per the direction of the CDC we decided to give a repeat of the second dose in the patient's right arm since we assumed less that half of the initial dose was administered.  CDC guidelines listed below:  If a lower-than-authorized dose volume is administered for any of the currently authorized vaccines, adhere to the following interim recommendation:  If more than half of the dose was administered, do not repeat the dose. If the dose given in error is the first dose, administer the second dose at the recommended interval of 28 days. If this dose is the second dose, the series is complete, and no additional doses are needed.  If less than half of the dose was administered or the proportion of the dose cannot be estimated, administer the authorized dose immediately in the opposite arm. If the dose given in error is the first dose, administer the second dose at the recommended interval of 28 days from the date of receipt of the valid dose (not the date of receipt of the erroneous dose).
Nauseous, vomiting, headache, light headed, disorientation, vision changes, jaw pain, lymph node inflammation, lethargy, mental confusion, sense of hopelessness, 15 days taper Prednisone, ibuprofen, acetaminophen, still currently experiencing symptoms today
Injection site swelling 24 hours later; This is a spontaneous report from a non-contactable consumer (patient). An elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 18Feb2021 09:00 as dose number unknown, single for COVID-19 immunisation at hospital. The patient medical history and concomitant medications were not reported. The patient previously took codeine and experienced drug allergy, prednisone for inflammation (prednisone 5mg). Patient did not received other vaccine within four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced injection site swelling 24 hours later on 19Feb2021 09:00. No treatment was given for the adverse event. Patient did not tested for COVID post vaccination. Outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Narrative: Pt was a 83yo male who was admitted to the hospital and transferred downtown, where he expired on 7/9/2021. No other information was presented. Pt received the COVID vaccines on 2/22/2021 and 3/22/2021. Vaccine unlikely to be related to cause of death.
Information has been received from a physician concerning a 11 to 12 year old female who was vaccinated with Gardasil. One week after vaccination, the patient presented with what appeared to be facial Bell's Palsy of the seventh nerve involvement. The physician was then practicing as an Urgent Care physician and sent the patient to the ER for further help. The physician is now practicing at a pediatrician's office and could not follow up on this experience. No further information is available.
Soreness at injection site starting night of 2/15. Ulnar numbness abs tingling in forearm and hand of left arm.  (Same side as injection)
This report describes joint pain and swelling in a male vaccinee in his fifth decade who received LYMErix. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. Medical history included hyperprolactinemia and decreased testosterone concentration. Concurrent conditions and concurrent medications were not provided. The vaccinee reportedly received LYMErix; the number of injections was not reported. In a statement of injuries, his attorney alleged that the vaccinee "suffers from pain and swelling in his joints as well as foot pain and he has difficulty sleeping. Also, he suffers from Ichthyosis Vulgaris in his lower legs, Nevi in his left axilla back and chest, and Lentigines in his back, shoulders and chest. In addition, he suffers from Seborrheic Keratoses in his hands, right wrist, right forears, right thigh and left leg." Time to onset following immunization, treatment, and outcomes of the alleged events were not reported. Per F/U 6/28/02: The pt experienced a wart on his right foot, fatigue and distal-lateral subungual onychomycosis bilateral Fallux. These were not reported as adverse events due to vaccine administration but were found during the course of review of the vaccinee's medical records. This following info was from medical records: Chief complaint of fatigue with standing; painful range of motion first metatarsphalangal joint (MPJ) bilateral; early distal-lateral subungual onychomycosis (DOS). Treatment plain: debridement performed and chemical cautery applied, prescription given for bilateral foot X-ray; wishes to self-treat wart. Advised orthotics and return with X-ray for review. The most recent info received on 6/11/02, did not specify the outcome of the reported events. The follow-up states on 2/16/00, Lyme IgG Western blot and rheumaoid factor were negative. On 10/19/00, the vaccinee was his family physician who noted, "still having bilateral feet pain, some arthritis of feet." On 3/8/01, the vaccinee reported to his family physician that he was "having sleeping problems." The physician noted, "Ambien not working anymore, sleeping 2-3 hours/night. Should he see a psychiatrist." The most recent info, received on 8/1/02, did not specify the outcomes of the reported events.
Exactly one week from vaccination, I am developing a rash about 4in x 1in a little bit below the site of injection. No pain, but a bit itchy. Seems to be covid arm.
Pt sleep for 6 hours after immunization, hard to arouse. Was pale and clammy for 1 week. Vomiting occurred that evening, lasted 3 days. Low temperature-"36". Mother did not report symptoms until 7/28/03.
A report has been received from a Physician concerning a 3 year old, Male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on 15-Jan-2014. The patient received expired FLUMIST on 15-Jan-2014. The outcome of the event of gave expired FLUMIST is unknown. The report was considered to be non-serious.
Patient presented to the ED and was subsequently hospitalized for hypotension, acute renal failure within 6 weeks of receiving COVID vaccination.
PT STATED HER THROAT WAS CLOSING OFF AND HER HEART WAS BEATING "BOOM BOOM" AFTER SHE GOT HER FIRST SHINGLES SHOT AND A FLU SHOT.  PT HAD HER DGTR DRIVE HER BACK TO THE PHARMACY. AT THIS TIME, PT DID REPORT A HISTORY OF PANIC ATTACKS WITH MRI'S AND OTHER SITUATIONS. WE MONITORED PT FOR 30 MINUTES, TAKING BLOOD PRESSURES AND HEART RATES. PT'S STATUS RESOLVED AND PT LEFT THE PHARMACY (daughter driving) AFTER PULSE <100 TIMES 2 AND BLOOD PRESSURE LESS THAT 140/90 TIMES TWO.
About an hour or so after the shot, continuing until now, only 36 hours later: A general sense of feeling quite ill, headache, extreme fatigue, weakness and sleepiness, muscle aches over the past 36 hrs since the shot occurred.  I have been in bed sleeping off and on feeling ill in waves.  I feel less ill for hours at a time, during which I get up out of bed and function relatively normally.  I felt completely fine (except for injection site achiness) until about an hour and a half after the shot, after which I went to sleep for several hours after which I felt better.    The major symptom is the general feeling of 'being sick'.
Had severe abdominal pain 3 hrs after shot, and went to Emergency Room at hospital where I was admitted and kept for 3 days.  CT scan showed inflammation in small bowel and Sigmoid colon
This spontaneous report was received from a physician via company presentative refers to a 13 year old patient (gender unknown). ON an unknown date when the patient was 12 months old, the patient was vaccinated with a dose of VARIVAX (Merck) (lot number, expiry date and route was not reported). On an unknown date at the age of 9 or 10 years, the patient developed shingles. Treatment was rendered for the event but it was unspecified. The outcome of developed shingles was reported as recovered. Additional information has been requested.
Very painful at site of injection, shortness of breath, Achy, Headache, Loss of Appetite, Dizziness, No Energy  Shortness of breath cleared up by late evening the day of injection; all other symptoms lasted through Wednesday, September 11.  Missed 3 days of work.
I started with a stuffy nose, throat irritation that progressed to a cough. Once I developed the cough I decided to get tested for COVID-19, on May 8, 2022. I work at an Outpatient Center and they ran a PCR COVID 19 Test that came back positive. Today I feel fine, my throat is not irritated and my cough is intermittent and more of a dry cough.